Haven’t posted for a while about Mr. Spouse21 until I had some data as his PSA began to tick up a few months ago. Last week a PET FDG confirmed recent bone and CT scans. Summary of main results: Multiple tracer avid osseous metastases. Most prominent involving right margin of T12.
Mr.Spouse was high Gleason, low PSA (3.38) at dx, 100% cores GL 9 with some 8s. Except for one brief uptick in ALP (63) in 2018, blood tests are always within normal range. Latest ALP a couple weeks ago was 43. Go figger since he now has a “hot” tumor on T12 spine, and multiple other small ones lit up.
PSAs post-chemo 2019-2023: 0.14-0.36 (earlier PSAs back to 2014 in profile)
6/6/23: 0.14
8/29/23: 0.21
11/29/23: 0.56
2/21/24: 1.18 (missing Jan. #)
3/26/24 1.76 1 mo. later (doubling time 3 months)
Testosterone: <3 (L)
Background of who he is and how he handled his PCa.
Mr. Spouse will be 80 in July. Yup, he's a Cancer! He’s had a nearly 10-year run with the standard treatments available in 2014. The results: two 4+ year periods of fairly stable disease with decent quality of life during both 4-year periods. We took full advantage of them: full family life; travels; lots of physical activities and adventures including Mr. S’s epic bike rides every summer I’ve written about on HU before.
We front loaded all the PCa running around to big cancer centers in the first year. After that, Mr. Spouse carried out treatment plans that accounted for his early and late comorbidities (four pacemakers so no MRIs); no RALP (early 2014 open abdominal appendectomy when he lost 6” of intestine, a factor that contributed to radiation proctitis later on, which is managed. ) Some neuropathy from chemo. He’s nearly 80 now, not 70, so there are the comorbidities of age + heavy, heavy treatment: total years of Lupron/Eligard (7 yrs and current); 9 weeks of radiation; 10 rounds of chemo; 3 yrs of Xgeva (started 6- month schedule recently). Failed Zytiga. It’s that Paul McCartney line in “Yesterday” “I’m not half the man I used to be.” (Only he'll always be the whole man to me.)
So what to do next?
Our local oncologist first floated the possibility of spot radiation of that T12 tumor. Mr. Spouse has vague, sporadic pains in that region but nothing acute so didn’t seem much interested right then. Then the onc said she could make arrangements with our pre-pandemic oncologist at Mass General in Boston to discuss possibility of Pluvicto. (local hospital is a satellite of MGH 90 miles away.) We have an appt. with “the big gun” on Monday and will have a lot of questions. One I’d like to float by the HU community first is the following in case it’s a stupid idea.
What about hitting the T12 tumor with spot radiation soon to slow the thing down for several months (hopefully) and start Pluvicto in late summer so Mr. S21 can better enjoy the summer in case Pluvicto proves to be debilitating? (We’re not wowed by some of the Pluvicto outcomes on HU in the last few months among older guys who were also heavily treated with ADT. If there are some 75 year old+ Pluvicto guys out there, or their caregivers, with good outcomes, please weigh in to give us some encouragement. Pluvicto has a short track record and so-so 30% success rate.)
Quality of life has driven several treatment decisions along the way. In 2019, we got the MGH onc’s green light to travel overseas for a month ahead of chemo, for example. Mr. Spouse tweaked start dates of ADT so he could enjoy some special family times. For us, QQL has sometimes been more of a priority than timing. I can’t tell from HU men’s accounts how fast their Pluvicto treatments needed to start—seems like a long time for those who went to Germany, India, etc. We also have a concern about spot radiation being too much radiation due to current proctitis and possible Pluvicto treatment right after.
Just wondering what the great minds think about spot radiating the T12 tumor to keep it from progressing and pushing off Pluvicto until late summer. Any thoughts?
Thanks for reading.